Homocysteine, fibrinogen and anti-ox-LDL antibody levels as markers of atherosclerosis in prepubertal obese children

Journal of Pediatric Endocrinology and Metabolism

Volumn 22, Issue 10, 2009, Pages 915-920

  Ezgü, Fatih ^a   Tümer, Leyla ^a   Özbay, Ferda ^a   Hasanoǧlu, Alev ^a   Biberoǧlu, Gürsel ^a   Aybay, Cemalettin ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Atherosclerosis; Children; Inflammation; Obesity; Puberty

Indexed keywords

BIOLOGICAL MARKER; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; HOMOCYSTEINE; INSULIN; LIPID; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET RESTRICTION; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; OBESITY; PREPUBERTY; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD;

EID: 71049181450     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2009.22.10.915     Document Type: Article

References (33)

1. Thomas NE, Baker JS, Davies B. Established and recently identified coronary heart disease risk factors in young people. Sports Med 2003; 33: 633-650.
2. Sudi K, Gallistl S, Payerl D, Aigner R, Moller R, Tafeit E, Borkenstein MH. Interrelationship between estimates of adiposity and body fat distribution with metabolic and hemostatic parametres in obese children. Metabolism 2001; 50: 681-687. (Pubitemid 32551822)
3. Winkler UH. Obesity and haemostasis. Arch Gynecol Obstet 1997; 261: 25-29.
4. Kopprasch S, Pietzsch J, Kuhlisch E, Fuecker K, Temelkova-Kurktschiev T, Hanefeld M, Kuhne H, Julius U, Graessler J. In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance. Diabetes 2002; 51: 3102-3106.
5. Kita T, Kume N, Minami M, Hayashida K, Murayama T, Sano H, Moriwaki H, Kataoka H, Nishi E, Horiuchi H, Arai H, Yokode M. Role of oxidised LDL in atherosclerosis. Ann NY Acad Sci 2001; 947: 199-205.
6. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssonen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339: 883-887.
7. Serin O, Konukoglu D, Firtina S, Mavis O. Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test. Horm Metab Res 2007; 39: 207-211. (Pubitemid 46580620)
8. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
9. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13-23.
10. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. N Engl J Med 2002; 346: 802-810.
11. Young-Hyman , Schlundt DG, Herman L, De Luca F, Counts D. Evaluation of the insulin resistance syndrome in 5- to 10-year old overweight/obese African-American children. Diabetes Care 2002; 24: 1359-1364.
12. Clauss A. Gerinnnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246.
13. te Poele-Pothoff MT, van den Berg M, Franken DG, Boers GH, Jakobs C, de Kroon IF, Eskes TK, Trijbels JM, Blom HJ. Three different methods for the determination of total homocysteine in plasma. Ann Clin Biochem 1995; 32: 218-220.
14. Craig WY, Poulin SE, Nelson CP, Ritchhie RF. An ELISA method for the detection and quantitation of IgG antibody against oxidised low density lipoprotein: the effects of blocking buffer and the method of data expression on experimental findings. Clin Chem 1994; 40: 882-888.
15. rd Ed. Columbus, OH: Lange/McGraw-Hill, 2001; 121-122.
16. rd Ed. Columbus, OH: Lange/McGraw-Hill, 2001; 114-115.
17. rd Ed. Columbus, OH: Lange/McGraw-Hill, 2001; 49.
18. rd Ed. Lange/McGraw-Hill, 2001; 118-121
19. Bao W, Srinivasan SR, Berenson GS. Plasma fibrinogen and its correlates in children from a biracial community: the Bogalusa Heart Study. Pediatr Res 1993; 33: 323-326. (Pubitemid 23095760)
20. Ferguson MA, Gutin B, Owens S, Litaker M, Tracy RP, Allison J. Fat distribution and hemostatic measures in obese children. Am J Clin Nutr 1998; 67: 1136-1140. (Pubitemid 28259499)
21. Shea S, Isasi CR, Couch S, Stare TJ, Tracy RP, Deckelbaum R, Talmud P, Berglund L, Humphries SE. Relations of plasma fibrinogen level in children to measures of obesity, the (G-455→A) mutation in the β-fibrinogen promoter gene, and family history of ischemic heart disease. Am J Epidemiol 1999; 150: 737-746.
22. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 1997; 82: 4916-4920.
23. 1-adrenergic antihypertensive agent, decreases serum oxidised LDL. Am J Hypertens 2001; 14: 267-270. (Pubitemid 32202711)
24. Vasankari T, Fogelholm M, Kukkonen-Harjula K, Nenonen A, Kujala U, Oja P, Vuori I, Pasanen P, Neuvonen K, Ahotupa M. Reduced oxidised low-density lipoprotein after weight reduction in obese premenopausal women. Int J Obes 2001; 25: 205-211. (Pubitemid 32158243)
25. Myara I, Alamowitch C, Michel O, Heudes D, Bariety J, Guy-Grand B, Chevalier J. Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients. Obes Res 2003; 11: 112-120. (Pubitemid 41137546)
26. Liuba P, Persson J, Luoma J, Yla-Herttuala S, Pesonen E. Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima-media. Eur Heart J 2003; 24: 515-521. (Pubitemid 36343097)
27. Willems D, Dorchy H, Dufrasne D. Serum antioxidant status and oxidised LDL in well-controlled young type 1 diabetic patients with and without subclinical complications. Atherosclerosis 1998; 137 (Suppl): S61-S64. (Pubitemid 28294209)
28. Wittenstein B, Klein M, Finkch B, Ullrich K, Kohlschutter A. Plasma antioxidants in pediatric patients with glycogen storage disease, diabetes mellitus and hypercholesterolemia. Free Rad Biol Med 2002; 33: 103-110. (Pubitemid 34681012)
29. Savolainen A, von Essen R, Leikola J, Alfthan G, Vaarala O, Palosuo T, Aho K. Antibodies against oxidised low-density lipoprotein in juvenile chronic arthritis. Scand J Rheumatol 1995; 24: 209-211.
30. Diwaddkar VA, Anderson JW, Bridges SR, Gowri MS, Oelgten PR. Postprandial low-density lipoproteins in type 2 diabetes are oxidized more extensively than fasting diabetes and control samples. Proc Soc Exp Biol Med 1999; 222: 178-184. (Pubitemid 29514133)
31. Sutherland WHF, Walker RJ, de Jong SA, van Rij AM, Phillips V, Walker HL. Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat. Arterioscler Thromb Vasc Biol 1999; 19: 1340-1347. (Pubitemid 29227656)
32. Osganian SK, Stampfer MJ, Spiegelman D, Rimm E, Cutler JA, Feldman HA, Montgomery DH, Webber LS, Lytle LA, Bausserman L, Nader PR. Distribution of and factors associated with serum homocysteine levels in children: child and adolescent trial for cardiovascular health. JAMA 1999; 281: 153-155.
33. Glowinska B, Urban M, Koput A, Galar M. New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents. Atherosclerosis 2003; 167: 275-286. (Pubitemid 36773527)